<DOC>
	<DOCNO>NCT02353806</DOCNO>
	<brief_summary>This phase IV prospective trial collect analyze information maternal pharmacokinetics amlodipine besylate time delivery postpartum lactation . The study also evaluate amlodipine concentration infant breastfeed mother take amlodipine besylate treatment chronic hypertension .</brief_summary>
	<brief_title>Pharmacokinetics Amlodipine Besylate Delivery During Lactation</brief_title>
	<detailed_description>We plan evaluate pharmacokinetics amlodipine besylate time delivery , determine transplacental passage drug occur . We also examine drug kinetics postpartum lactation establish whether amlodipine excrete breast milk . The outcomes interest plasma concentration amlodipine delivery drug concentration blood breast milk twenty-hour steady-state period follow milk-supply establishment . Fifteen patient already take 5 mg amlodipine pregnancy treatment chronic hypertension recruit antepartum Obstetric Complications Clinic Parkland Hospital . Only woman breastfeed eligible study . Patients elect participate study continue amlodipine 5 mg dose delivery postpartum period . Maternal blood drawn within one hour delivery fetal cord blood collect time delivery . Patients blood drawn 24 hour period begin postpartum day 2 delivery follow administration once-daily amlodipine dose . At blood draw , patient also use breast pump express breast milk pair analysis . Both blood breast milk amlodipine level calculate sample . The level use determine pharmacokinetics amlodipine peri- postpartum patient , include concentration plasma breast milk . In addition collect maternal data , range clinical information collect study patient 's infant include weight , Apgar score , hemodynamic parameter , physical examination hospital course . This information use screen potential complication associate infant exposure amlodipine . An infant blood sample also obtain conjunction routine neonatal blood collection occur 1-2 day postnatal life analyze determine serum amlodipine concentration breastfeed infant .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pregnancy-Induced</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>18 year old ; Pregnant female Already take amlodipine 5 mg treatment chronic hypertension pregnancy ; Hospitalized follow routine term vaginal delivery uncomplicated cesarean delivery Breastfeeding breast bottlefeeding infant Known kidney disease Delivery complicate chorioamnionitis , endometritis postpartum hemorrhage Administration great 5 mg amlodipine 24 hour period</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Amlodipine besylate</keyword>
	<keyword>Breast milk</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Chronic hypertension</keyword>
	<keyword>Pregnancy</keyword>
</DOC>